Lantheus Holdings Operating Income 2013-2025 | LNTH

Lantheus Holdings operating income from 2013 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Lantheus Holdings Operating Income 2013-2025 | LNTH

Lantheus Holdings operating income from 2013 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$215.2B
Boston Scientific (BSX)$153.3B
Stryker (SYK)$148.6B
EssilorLuxottica (ESLOY)$131.1B
Medtronic (MDT)$114.9B
Lonza Group Ag (LZAGY)$49.8B
Haleon (HLN)$43.1B
ResMed (RMD)$37.8B
GE HealthCare Technologies (GEHC)$34.8B
Agilent Technologies (A)$32.4B
Terumo (TRUMY)$23.9B
Koninklijke Philips (PHG)$23.7B
Insulet (PODD)$20B
Zimmer Biomet Holdings (ZBH)$18.4B
Baxter (BAX)$14.3B
Smith & Nephew SNATS (SNN)$13.2B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$6.7B
Prestige Consumer Healthcare (PBH)$3.7B
Perrigo (PRGO)$3.7B
Haemonetics (HAE)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.3B
ICU Medical (ICUI)$3B
LeMaitre Vascular (LMAT)$1.8B
QuidelOrtho (QDEL)$1.7B
AtriCure (ATRC)$1.4B
Acuren (TIC)$1.4B
AdaptHealth (AHCO)$1.2B